Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > EBIT

Acadia Pharmaceutica EBIT Chart (ACAD)

Acadia Pharmaceutica annual/quarterly EBIT from 2010 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Acadia Pharmaceutica EBIT for the quarter ending June 06, 2020 was $-44m a -3.21% increase of 1m year over year
  • Acadia Pharmaceutica EBIT for the last 12 months ending June 06, 2020 was $-235m a -9.38% increase of 22m year over year
  • Acadia Pharmaceutica Annual EBIT for 2019 was $-247m a -0.36% increase of 1m from 2018
  • Acadia Pharmaceutica Annual EBIT for 2018 was $-247m a -18.17% increase of 45m from 2017
  • Acadia Pharmaceutica Annual EBIT for 2017 was $-292m a 6.70% decrease of -20m from 2016
Other Income Statement Metrics:
  • Acadia Pharmaceutica EBITDA for the quarter ending December 12, 2018 was $-67m a 18.74% decrease of -12m year over year
  • Acadia Pharmaceutica Net Income for the quarter ending December 12, 2018 was $-65m a 17.10% decrease of -11m year over year
  • Acadia Pharmaceutica Total Revenue for the quarter ending September 09, 2018 was $58m a 25.29% increase of 15m year over year
View Chart On Koyfin

Quarterly ACAD EBIT Data

06/2020$-44m
03/2020$-90m
12/2019$-56m
09/2019$-45m
06/2019$-57m
03/2019$-88m
12/2018$-67m
09/2018$-61m
06/2018$-64m
03/2018$-55m

Annual ACAD EBIT Data

2019$-247m
2018$-247m
2017$-292m
2016$-273m
2015$-155m
2014$-93m
2013$-38m
2012$-21m
2011$-23m
2010$15m